Metsera, Maze secure combined $415 million in IPOs
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go public.
Related Articles
Sandeep Gautam (@gautamsandmd) • Instagram photos and videos
1 Followers, 5 Following, 2 Posts – See Instagram photos and videos from Sandeep Gautam (@gautamsandmd)
Ushering in a New Era of Hypertension Canada Guidelines: A Roadmap of What Lies Ahead
Hypertension is a global health problem with an estimated prevalence of 32% worldwide and increasing.1 In fact, hypertension is the most common modifiable risk factor…
Inconsistent Troponin Testing in US EDs Warrants Closer Look
New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain | Vertex Pharmaceuticals Newsroom
— JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than…
Smarter Healthcare Through Collaborative Intelligence
We’re thrilled to announce Season 2 of The Digital Healthcare Experience! Setting the bar high with Dr. Ami Bhatt, Chief Innovation Officer at the American…
Hiring! Immunology Postdoc
IMMUNOLOGY POSTDOC OPENING! Overview: We are seeking talented and enthusiastic postdoctoral scholars who have completed PhD or MD/PhD training, to join our lab focused on…
Frank J. Hildner, Founding Member of SCAI, Dies at 90
An early pioneer in the interventional community, Hildner advocated for sharing experiences to improve patient outcomes.
Penumbra Launches Element Vascular Access System for VTE – Endovascular Today
January 29, 2025—Penumbra announced that it has launched the Element vascular access system, a laser-cut hypotube sheath designed for treating v
